Fludara Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Fludarabine phosphate

Indications/Uses

B-cell chronic lymphocytic leukaemia in patients w/ sufficient bone marrow reserves. 1st-line treatment in patients w/ advanced disease, Rai stages III/IV (Binet stage C) or Rai stages I/II (Binet stage A/B) where the patient has disease-related symptoms or evidence of progressive disease.

Dosage/Direction for Use

IV Adult 25 mg/m² daily for 5 consecutive days every 28 days. Renal impairment (CrCl 30-70 mL/min) Reduce dose up to 50%.

Contraindications

Hypersensitivity. Decompensated haemolytic anaemia. Renal impairment w/ CrCl <30 mL/min. Lactation.

MIMS Class

Cytotoxic Chemotherapy

ATC Classification

L01BB05 - fludarabine ; Belongs to the class of antimetabolites, purine analogues. Used in the treatment of cancer.

Regulatory Classification

POM

Presentation/Packing

Form

Fludara powd for inj 50 mg

Packing/Price

1's

Fludara

fludarabine

Manufacturer:

Intendis